Log in
Enquire now
Pdc*Line Pharma

Pdc*Line Pharma

Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides

OverviewStructured DataIssuesContributors

Contents

pdc-line-pharma.com
Is a
Company
Company
Organization
Organization
Funding round
Funding round

Company attributes

Industry
Tissue engineering
Tissue engineering
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biotechnology
Biotechnology
Cell therapy
Cell therapy
Stem cell
Stem cell
Engineering
Engineering
...
Location
Belgium
Belgium
France
France
Grenoble
Grenoble
Liège
Liège
B2X
B2C
B2C
CEO
Pitchbook URL
pitchbook.com/profiles...168705-46
Number of Employees (Ranges)
1 – 10
Email Address
Full Address
Liège, Wallonia, Belgium
Investors
‌
SRIW
0
Sfpi-Fpim
Sfpi-Fpim
0
‌
Meusinvest
0
Founded Date
2014
Total Funding Amount (USD)
43,900,000
Latest Funding Round Date
January 18, 2024
Latest Funding Type
Series B
Series B
Country
France
France
Headquarters
Grenoble
Grenoble

Funding Round attributes

Funding Type
Series B
Series B
Funded Company
Pdc*Line Pharma
Pdc*Line Pharma
Funding Round Amount (USD)
13,000,000
Funding Round Date
December 1, 2021

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
8,700,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Pdc*Line Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.